Search by Drug Name or NDC
NDC 59212-0425-10 Donnatal .0194; .1037; 16.2; .0065 mg/1; mg/1; mg/1; mg/1 Details
Donnatal .0194; .1037; 16.2; .0065 mg/1; mg/1; mg/1; mg/1
Donnatal is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is ATROPINE SULFATE; HYOSCYAMINE SULFATE; PHENOBARBITAL; SCOPOLAMINE HYDROBROMIDE.
MedlinePlus Drug Summary
Belladonna alkaloid combinations and phenobarbital are used to relieve cramping pains in conditions such as irritable bowel syndrome and spastic colon. They also are used with other medicine to treat ulcers. These medicines decrease the motion of the stomach and intestines and the secretion of stomach fluids, including acid. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 59212-0425-10Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Belladonna Alkaloid Combinations and Phenobarbital
Product Information
NDC | 59212-0425 |
---|---|
Product ID | 59212-425_29d98e6b-05f6-4719-bda4-66d681279738 |
Associated GPIs | 49109904050320 |
GCN Sequence Number | 004777 |
GCN Sequence Number Description | phenobarb/hyoscy/atropine/scop TABLET 16.2 MG ORAL |
HIC3 | J2A |
HIC3 Description | BELLADONNA ALKALOIDS |
GCN | 74070 |
HICL Sequence Number | 035019 |
HICL Sequence Number Description | PHENOBARBITAL/HYOSCYAMINE SULF/ATROPINE SULF/SCOPOLAMINE HB |
Brand/Generic | Brand |
Proprietary Name | Donnatal |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | .0194; .1037; 16.2; .0065 |
Active Ingredient Units | mg/1; mg/1; mg/1; mg/1 |
Substance Name | ATROPINE SULFATE; HYOSCYAMINE SULFATE; PHENOBARBITAL; SCOPOLAMINE HYDROBROMIDE |
Labeler Name | Concordia Pharmaceuticals Inc. |
Pharmaceutical Class | Anticholinergic [EPC], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
DEA Schedule | CIV |
Marketing Category | UNAPPROVED DRUG OTHER |
Application Number | n/a |
Listing Certified Through | 2024-12-31 |
Package
NDC 59212-0425-10 (59212042510)
NDC Package Code | 59212-425-10 |
---|---|
Billing NDC | 59212042510 |
Package | 100 TABLET in 1 BOTTLE, PLASTIC (59212-425-10) |
Marketing Start Date | 1980-12-30 |
NDC Exclude Flag | N |
Pricing Information | N/A |